Donepezil - CAS 120014-06-4
Catalog number:
120014-06-4
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C24H29NO3
Molecular Weight:
379.49
COA:
Inquire
Targets:
AChE
Description:
Donepezil, also called Aricept, a centrally acting reversible acetyl cholinesterase inhibitor that the FDA has also approved for the treatment of moderate to severe Alzheimer’s disease. It readily crosses the blood-brain barrier to reduce the breakdown of acetylcholine by increasing the concentration of acetylcholine through reversible inhibition of its hydrolysis by acetylcholinesterase.
Publictions citing BOC Sciences Products
  • >> More
Brife Description:
A centrally acting reversible Acetylcholinesterase inhibitor AChE: IC50 = 1.7 nM (rat); IC50 = 2 nM (human); IC50 = 4.2 nM (bovine);
Appearance:
A crystalline solid
Synonyms:
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one; 1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine hydrochloride; donepezil; 120014-06-4; Aricept; 2-((1-Benzylpiperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one; Eranz; Aricept ODT; donepezilo; donepezilum; Donepezil [INN:BAN]; CHEMBL502; Donepezil (INN); Donaz (TN); donepezil hydrochloride; donepezilium oxalate trihydrate; E 2020; E-2020; E2020; 2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one; (RS)-2-[(1-BENZYL-PIPERIDIN-4-YL)METHYL]-5,6-DIMETHOXYINDAN-1-ONE
Solubility:
Soluble to ~50 mg/ml in chloroform, to ~25 mg/ml in acetone, to 2.93 mg/L in water
Storage:
Store in a cool and dry place and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years).
MSDS:
Inquire
Boiling Point:
527.9°C at 760 mmHg
Melting Point:
207℃
Density:
1.141 g/cm3
InChIKey:
ADEBPBSSDYVVLD-UHFFFAOYSA-N
InChI:
1S/C24H29NO3/c1-27-22-14-19-13-20(24(26)21(19)15-23(22)28-2)12-17-8-10-25(11-9-17)16-18-6-4-3-5-7-18/h3-7,14-15,17,20H,8-13,16H2,1-2H3
Canonical SMILES:
COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC
1. A gorge-spanning, high-affinity cholinesterase inhibitor to explore β-amyloid plaques
Paul W. Elsinghorst, Wolfgang Hartig, Simone Goldhammer, Jens Groscheb,c and Michael Gutschow*. Org. Biomol. Chem., 2009, 7, 3940–3946
To corroborate our initial conclusion, that 13 binds to AChE inside plaques, staining experiments were subsequently repeated in the presence and absence of fasciculin-2, a peptidic (Mr =6500 , IC50 = 24 nM), high-affinity AChE inhibitor. No significant difference in staining by 13 (6.8 mM) was observed as a result of the presence or absence of fasciculin-2(3.1 mM). A reduction in fluorescence after treatment with fasciculin-2 would have provided ultimate proof of 13 binding to AChE inside β-amyloid plaques. The unaltered observation leads to further questions, e.g. whether fasciculin-2 will penetrate into the b-amyloid plaque core, and whether fasciculin-2 can bind to AChE inside the lattice of aggregated Ab. To exclude molecular size as a question of debate, comparable experiments were carried out using donepezil hydrochloride (Mr = 416.0), which occupies the enzyme gorge in a similar fashion as expected for 13. Again, no attenuation of staining intensity caused by 13 (6.8 mM) was observed in brain samples pretreated with donepezil (145 mM) as shown in Fig.4. The same result was observed after simultaneous application of equipotent concentrations (145 mM donepezil, 6.8 mM13) or excess of donepezil (1450 mM, 6.8 mM13). Binding of 13 to AChE inside b-amyloid plaques seems therefore rather unlikely.
2. Biocentri-voltammetry for the enzyme assay: a model study
Serdar C ¸ evik, Suna Timur and Ulku Anik*. RSC Adv., 2012, 2, 4299–4303
For the inhibition study, as mentioned in the experimental, a Donepezil-based AD drug was analyzed. After the preparation of the sample that was taken from the drug, the measurement was conducted by introducing Donepezil together with ATCh and AChE in the reaction medium. Then the centrifugation was applied and the voltammogram was recorded (Fig. 7). As can be seen from the figure, a sharp decrease was obtained at the current value, demonstrating the inhibition of Donepezil. Based on the obtained current values and following the necessary formula, the inhibition was calculated as 80%.
3. An immobilization multienzyme microfluidic chip for acetylcholinesterase inhibition assay by fluorescence method
Yulan Tang, Sufang Liu,* Rongbiao Pi and Zhiyi Cheng*. RSC Adv.,2016, 6,20867–20875
The enzyme activity and inhibitor assays were carried out in prepared microchip device and described below briefly. Substrate ACh (or ACh mixed with donepezil in inhibition assay) was injected into the system from C1 and C2 (high and low concentration) to generate concentration gradient and catalyzed by immobilized enzyme in reaction wells. After incubation for 10 min, L-tyrosine/HRP mixture solution was injected from C3 and C4, and then mixed with product H2O2 through long sinuous micro-channels. Finally, the fluorescent dimer in detection chambers was quantified after 5 min.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related AChE Products


CAS 209394-46-7 Ladostigil tartrate

Ladostigil tartrate
(CAS: 209394-46-7)

Ladostigil, also called as TV-3,326, is a novel neuroprotective agent developed to treat neurodegenerative disorders sunch as Alzheimer’s disease. Ladostigil is...

CAS 209349-27-4 Ladostigil

Ladostigil
(CAS: 209349-27-4)

Ladostigil, also called as TV-3,326, is a novel neuroprotective agent developed to treat neurodegenerative disorders sunch as Alzheimer’s disease. Ladostigil is...

CAS 510-77-0 Galanthaminone

Galanthaminone
(CAS: 510-77-0)

Galantamine is a competitive and reversible cholinesterase(AChE) inhibitor, which is used for the treatment of mild to moderate Alzheimer's disease and various ...

Icopezil maleate
(CAS: 145815-98-1)

The maleate salt form of Icopezil, a benzoxazol derivative, has been found to be an acetylcholinesterase inhibitor and was once studied for the treatment of Alz...

CAS 101-26-8 Pyridostigmine bromide

Pyridostigmine bromide
(CAS: 101-26-8)

Pyridostigmine is a parasympathomimetic and a reversible cholinesterase inhibitor.

CAS 51-15-0 Pralidoxime chloride

Pralidoxime chloride
(CAS: 51-15-0)

Pralidoxime is an antidote to organophosphate pesticides, reactivates the enzyme cholinesterase by cleaving the phosphate-ester bond formed between the organoph...

Neostigmine Iodide
(CAS: 1212-37-9)

This active molecular is a reversible acetylcholinesterase inhibitor as a parasympathomimetic compound under the development of Flamel Technologies. Neostigmine...

Ganstigmine hydrochloride
(CAS: 412044-92-9)

Ganstigmine hydrochloride is a selective inhibitor of AChE as a useful therapeutic drug for Alzheimer's disease patients with cognitive impairment accompanied b...

CAS 1953-04-4 Galanthamine HBr

Galanthamine HBr
(CAS: 1953-04-4)

Galanthamine is an AChE inhibitor with IC50 of 0.35 μM, exhibits 50-fold selectivity against butyryl-cholinesterase.

CAS 123441-03-2 Rivastigmine

Rivastigmine
(CAS: 123441-03-2)

Rivastigmine, a carbamate derivative, is a reversible cholinesterase inhibitor that is selective for the central nervous system to treat Alzheimer's Disease.

CAS 59-99-4 Neostigmine

Neostigmine
(CAS: 59-99-4)

Neostigmine is a parasympathomimetic compound, which acts as a reversible acetylcholinesterase inhibitor. It is used in the treatment of myasthenia gravis, ogil...

CAS 120011-70-3 Donepezil HCl

Donepezil HCl
(CAS: 120011-70-3)

Donepezil is a specific and potent AChE inhibitor for bAChE and hAChE with IC50 of 8.12 nM and 11.6 nM , respectively.

CAS 13473-38-6 Pipenzolate

Pipenzolate
(CAS: 13473-38-6)

Pipenzolate, a muscarinic receptor antagonist, commonly existed as bromide salt form and could be used as a spasmolytic and could probably effective in aid ther...

CAS 548-66-3 Drofenine hydrochloride

Drofenine hydrochloride
(CAS: 548-66-3)

Drofenine hydrochloride is a widely used anticholinergic acts on smooth muscle to stop muscle spasms.

CAS 120014-06-4 Donepezil

Donepezil
(CAS: 120014-06-4)

Donepezil, also called Aricept, a centrally acting reversible acetyl cholinesterase inhibitor that the FDA has also approved for the treatment of moderate to se...

CAS 102518-79-6 (-)-Huperzine A (HupA)

(-)-Huperzine A (HupA)
(CAS: 102518-79-6)

(-)-Huperzine A is a potent, highly specific and reversible inhibitor of acetylcholinesterase (AChE) with Ki of 7 nM, exhibiting 200-fold more selectivity for G...

CAS 129101-54-8 Rivastigmine Tartrate

Rivastigmine Tartrate
(CAS: 129101-54-8)

Rivastigmine Tartrate is a cholinesterase inhibitor with IC50 of 5.5 μM, and used as a parasympathomimetic or cholinergic agent for the treatment of mild to mod...

CAS 120786-18-7 (±)-Huperzine A

(±)-Huperzine A
(CAS: 120786-18-7)

Huperzine A exhibited protective effects against d-gal-induced hepatotoxicity and inflamm-aging by inhibiting AChE activity and via the activation of the cholin...

CAS 116-38-1 Edrophonium chloride

Edrophonium chloride
(CAS: 116-38-1)

Edrophonium chloride is a reversible Acetylcholinesterase inhibitor which is effective in avoiding the decomposition of the neurotransmitter acetylcholine compe...

CAS 51-60-5 Neostigmine Methylsulfate

Neostigmine Methylsulfate
(CAS: 51-60-5)

Neostigmine methyl sulfate is a cholinesterase inhibitor used in the treatment of myasthenia gravis, can not cross the blood-brain barrier.

Chemical Structure

CAS 120014-06-4 Donepezil

Quick Inquiry

Verification code

Featured Items